EP2428254B1 - Process for treating an asbestos containing material - Google Patents
Process for treating an asbestos containing material Download PDFInfo
- Publication number
- EP2428254B1 EP2428254B1 EP11175285A EP11175285A EP2428254B1 EP 2428254 B1 EP2428254 B1 EP 2428254B1 EP 11175285 A EP11175285 A EP 11175285A EP 11175285 A EP11175285 A EP 11175285A EP 2428254 B1 EP2428254 B1 EP 2428254B1
- Authority
- EP
- European Patent Office
- Prior art keywords
- asbestos
- process according
- milk whey
- anyone
- hydrothermal
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Active
Links
- 239000010425 asbestos Substances 0.000 title claims description 79
- 229910052895 riebeckite Inorganic materials 0.000 title claims description 79
- 239000000463 material Substances 0.000 title claims description 54
- 238000000034 method Methods 0.000 title claims description 46
- 230000008569 process Effects 0.000 title claims description 39
- 235000013336 milk Nutrition 0.000 claims description 48
- 239000008267 milk Substances 0.000 claims description 48
- 210000004080 milk Anatomy 0.000 claims description 48
- 239000005862 Whey Substances 0.000 claims description 45
- 102000007544 Whey Proteins Human genes 0.000 claims description 45
- 108010046377 Whey Proteins Proteins 0.000 claims description 45
- MUBZPKHOEPUJKR-UHFFFAOYSA-N Oxalic acid Chemical compound OC(=O)C(O)=O MUBZPKHOEPUJKR-UHFFFAOYSA-N 0.000 claims description 27
- 238000011282 treatment Methods 0.000 claims description 26
- JVTAAEKCZFNVCJ-UHFFFAOYSA-N lactic acid Chemical compound CC(O)C(O)=O JVTAAEKCZFNVCJ-UHFFFAOYSA-N 0.000 claims description 18
- 239000011159 matrix material Substances 0.000 claims description 18
- 239000004568 cement Substances 0.000 claims description 17
- 239000007790 solid phase Substances 0.000 claims description 14
- 238000001027 hydrothermal synthesis Methods 0.000 claims description 12
- 239000004310 lactic acid Substances 0.000 claims description 9
- 235000014655 lactic acid Nutrition 0.000 claims description 9
- 235000006408 oxalic acid Nutrition 0.000 claims description 9
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims description 9
- 230000002378 acidificating effect Effects 0.000 claims description 8
- 238000000227 grinding Methods 0.000 claims description 8
- BDAGIHXWWSANSR-UHFFFAOYSA-N methanoic acid Natural products OC=O BDAGIHXWWSANSR-UHFFFAOYSA-N 0.000 claims description 6
- 239000007791 liquid phase Substances 0.000 claims description 5
- 150000007524 organic acids Chemical class 0.000 claims description 5
- 150000003839 salts Chemical class 0.000 claims description 5
- 238000003756 stirring Methods 0.000 claims description 5
- 229910052799 carbon Inorganic materials 0.000 claims description 4
- OSWFIVFLDKOXQC-UHFFFAOYSA-N 4-(3-methoxyphenyl)aniline Chemical compound COC1=CC=CC(C=2C=CC(N)=CC=2)=C1 OSWFIVFLDKOXQC-UHFFFAOYSA-N 0.000 claims description 3
- 239000002738 chelating agent Substances 0.000 claims description 3
- 235000019253 formic acid Nutrition 0.000 claims description 3
- 238000002485 combustion reaction Methods 0.000 claims description 2
- 235000002639 sodium chloride Nutrition 0.000 claims description 2
- 238000009997 thermal pre-treatment Methods 0.000 claims description 2
- 239000000047 product Substances 0.000 description 11
- 238000010335 hydrothermal treatment Methods 0.000 description 10
- 238000004519 manufacturing process Methods 0.000 description 10
- 229910052620 chrysotile Inorganic materials 0.000 description 9
- 239000000203 mixture Substances 0.000 description 9
- CWBIFDGMOSWLRQ-UHFFFAOYSA-N trimagnesium;hydroxy(trioxido)silane;hydrate Chemical compound O.[Mg+2].[Mg+2].[Mg+2].O[Si]([O-])([O-])[O-].O[Si]([O-])([O-])[O-] CWBIFDGMOSWLRQ-UHFFFAOYSA-N 0.000 description 9
- VTYYLEPIZMXCLO-UHFFFAOYSA-L Calcium carbonate Chemical compound [Ca+2].[O-]C([O-])=O VTYYLEPIZMXCLO-UHFFFAOYSA-L 0.000 description 8
- 230000009466 transformation Effects 0.000 description 8
- 239000002699 waste material Substances 0.000 description 8
- CURLTUGMZLYLDI-UHFFFAOYSA-N Carbon dioxide Chemical compound O=C=O CURLTUGMZLYLDI-UHFFFAOYSA-N 0.000 description 7
- 229910052500 inorganic mineral Inorganic materials 0.000 description 7
- 239000011707 mineral Substances 0.000 description 7
- 239000012071 phase Substances 0.000 description 7
- PXHVJJICTQNCMI-UHFFFAOYSA-N Nickel Chemical compound [Ni] PXHVJJICTQNCMI-UHFFFAOYSA-N 0.000 description 6
- 230000001580 bacterial effect Effects 0.000 description 6
- 230000003247 decreasing effect Effects 0.000 description 6
- 230000009471 action Effects 0.000 description 5
- 231100001261 hazardous Toxicity 0.000 description 5
- 239000000126 substance Substances 0.000 description 5
- XEEYBQQBJWHFJM-UHFFFAOYSA-N Iron Chemical compound [Fe] XEEYBQQBJWHFJM-UHFFFAOYSA-N 0.000 description 4
- FYYHWMGAXLPEAU-UHFFFAOYSA-N Magnesium Chemical compound [Mg] FYYHWMGAXLPEAU-UHFFFAOYSA-N 0.000 description 4
- VYPSYNLAJGMNEJ-UHFFFAOYSA-N Silicium dioxide Chemical compound O=[Si]=O VYPSYNLAJGMNEJ-UHFFFAOYSA-N 0.000 description 4
- 239000002253 acid Substances 0.000 description 4
- 150000007513 acids Chemical class 0.000 description 4
- 229910000019 calcium carbonate Inorganic materials 0.000 description 4
- 229910002092 carbon dioxide Inorganic materials 0.000 description 4
- 230000007613 environmental effect Effects 0.000 description 4
- 239000011777 magnesium Substances 0.000 description 4
- 229910052749 magnesium Inorganic materials 0.000 description 4
- VNWKTOKETHGBQD-UHFFFAOYSA-N methane Chemical compound C VNWKTOKETHGBQD-UHFFFAOYSA-N 0.000 description 4
- 235000018102 proteins Nutrition 0.000 description 4
- 102000004169 proteins and genes Human genes 0.000 description 4
- 108090000623 proteins and genes Proteins 0.000 description 4
- 150000004760 silicates Chemical class 0.000 description 4
- 241000894006 Bacteria Species 0.000 description 3
- 238000010306 acid treatment Methods 0.000 description 3
- 239000000654 additive Substances 0.000 description 3
- 230000015572 biosynthetic process Effects 0.000 description 3
- 239000001569 carbon dioxide Substances 0.000 description 3
- 238000006243 chemical reaction Methods 0.000 description 3
- 239000000470 constituent Substances 0.000 description 3
- 239000013078 crystal Substances 0.000 description 3
- 239000004744 fabric Substances 0.000 description 3
- 238000001914 filtration Methods 0.000 description 3
- 230000036541 health Effects 0.000 description 3
- 238000002844 melting Methods 0.000 description 3
- 230000008018 melting Effects 0.000 description 3
- 238000013048 microbiological method Methods 0.000 description 3
- 229910052759 nickel Inorganic materials 0.000 description 3
- 239000010453 quartz Substances 0.000 description 3
- 238000003892 spreading Methods 0.000 description 3
- 230000007480 spreading Effects 0.000 description 3
- 238000007669 thermal treatment Methods 0.000 description 3
- 230000001131 transforming effect Effects 0.000 description 3
- IJGRMHOSHXDMSA-UHFFFAOYSA-N Atomic nitrogen Chemical compound N#N IJGRMHOSHXDMSA-UHFFFAOYSA-N 0.000 description 2
- OYPRJOBELJOOCE-UHFFFAOYSA-N Calcium Chemical compound [Ca] OYPRJOBELJOOCE-UHFFFAOYSA-N 0.000 description 2
- 241000196324 Embryophyta Species 0.000 description 2
- VEXZGXHMUGYJMC-UHFFFAOYSA-N Hydrochloric acid Chemical compound Cl VEXZGXHMUGYJMC-UHFFFAOYSA-N 0.000 description 2
- GUBGYTABKSRVRQ-QKKXKWKRSA-N Lactose Natural products OC[C@H]1O[C@@H](O[C@H]2[C@H](O)[C@@H](O)C(O)O[C@@H]2CO)[C@H](O)[C@@H](O)[C@H]1O GUBGYTABKSRVRQ-QKKXKWKRSA-N 0.000 description 2
- -1 Mg2+ ions Chemical class 0.000 description 2
- ZLMJMSJWJFRBEC-UHFFFAOYSA-N Potassium Chemical compound [K] ZLMJMSJWJFRBEC-UHFFFAOYSA-N 0.000 description 2
- 238000009825 accumulation Methods 0.000 description 2
- 229910052661 anorthite Inorganic materials 0.000 description 2
- 230000004888 barrier function Effects 0.000 description 2
- 238000002306 biochemical method Methods 0.000 description 2
- 239000006227 byproduct Substances 0.000 description 2
- 239000011575 calcium Substances 0.000 description 2
- 229910052791 calcium Inorganic materials 0.000 description 2
- 150000004649 carbonic acid derivatives Chemical class 0.000 description 2
- 239000005018 casein Substances 0.000 description 2
- BECPQYXYKAMYBN-UHFFFAOYSA-N casein, tech. Chemical compound NCCCCC(C(O)=O)N=C(O)C(CC(O)=O)N=C(O)C(CCC(O)=N)N=C(O)C(CC(C)C)N=C(O)C(CCC(O)=O)N=C(O)C(CC(O)=O)N=C(O)C(CCC(O)=O)N=C(O)C(C(C)O)N=C(O)C(CCC(O)=N)N=C(O)C(CCC(O)=N)N=C(O)C(CCC(O)=N)N=C(O)C(CCC(O)=O)N=C(O)C(CCC(O)=O)N=C(O)C(COP(O)(O)=O)N=C(O)C(CCC(O)=N)N=C(O)C(N)CC1=CC=CC=C1 BECPQYXYKAMYBN-UHFFFAOYSA-N 0.000 description 2
- 235000021240 caseins Nutrition 0.000 description 2
- 239000000919 ceramic Substances 0.000 description 2
- 235000013351 cheese Nutrition 0.000 description 2
- 239000003153 chemical reaction reagent Substances 0.000 description 2
- 239000011248 coating agent Substances 0.000 description 2
- 238000000576 coating method Methods 0.000 description 2
- 150000001875 compounds Chemical class 0.000 description 2
- 238000001816 cooling Methods 0.000 description 2
- 238000002425 crystallisation Methods 0.000 description 2
- 230000008025 crystallization Effects 0.000 description 2
- 235000013365 dairy product Nutrition 0.000 description 2
- 230000006378 damage Effects 0.000 description 2
- GWWPLLOVYSCJIO-UHFFFAOYSA-N dialuminum;calcium;disilicate Chemical compound [Al+3].[Al+3].[Ca+2].[O-][Si]([O-])([O-])[O-].[O-][Si]([O-])([O-])[O-] GWWPLLOVYSCJIO-UHFFFAOYSA-N 0.000 description 2
- 230000000694 effects Effects 0.000 description 2
- 239000003925 fat Substances 0.000 description 2
- 239000000835 fiber Substances 0.000 description 2
- 239000010440 gypsum Substances 0.000 description 2
- 229910052602 gypsum Inorganic materials 0.000 description 2
- 238000010438 heat treatment Methods 0.000 description 2
- 229910052742 iron Inorganic materials 0.000 description 2
- 239000008101 lactose Substances 0.000 description 2
- 239000007788 liquid Substances 0.000 description 2
- 229910001425 magnesium ion Inorganic materials 0.000 description 2
- WPBNNNQJVZRUHP-UHFFFAOYSA-L manganese(2+);methyl n-[[2-(methoxycarbonylcarbamothioylamino)phenyl]carbamothioyl]carbamate;n-[2-(sulfidocarbothioylamino)ethyl]carbamodithioate Chemical compound [Mn+2].[S-]C(=S)NCCNC([S-])=S.COC(=O)NC(=S)NC1=CC=CC=C1NC(=S)NC(=O)OC WPBNNNQJVZRUHP-UHFFFAOYSA-L 0.000 description 2
- 229910052751 metal Inorganic materials 0.000 description 2
- 239000002184 metal Substances 0.000 description 2
- 229910021645 metal ion Inorganic materials 0.000 description 2
- 239000003345 natural gas Substances 0.000 description 2
- 235000005985 organic acids Nutrition 0.000 description 2
- 150000003891 oxalate salts Chemical class 0.000 description 2
- 239000005014 poly(hydroxyalkanoate) Substances 0.000 description 2
- 229920000903 polyhydroxyalkanoate Polymers 0.000 description 2
- 229920000642 polymer Polymers 0.000 description 2
- 239000011591 potassium Substances 0.000 description 2
- 229910052700 potassium Inorganic materials 0.000 description 2
- 230000001681 protective effect Effects 0.000 description 2
- 239000002893 slag Substances 0.000 description 2
- 239000007787 solid Substances 0.000 description 2
- 238000005507 spraying Methods 0.000 description 2
- 241000195940 Bryophyta Species 0.000 description 1
- 229920003043 Cellulose fiber Polymers 0.000 description 1
- 241000233866 Fungi Species 0.000 description 1
- 241000385654 Gymnothorax tile Species 0.000 description 1
- 241000186660 Lactobacillus Species 0.000 description 1
- 244000199866 Lactobacillus casei Species 0.000 description 1
- 235000013958 Lactobacillus casei Nutrition 0.000 description 1
- 240000006024 Lactobacillus plantarum Species 0.000 description 1
- 235000013965 Lactobacillus plantarum Nutrition 0.000 description 1
- JLVVSXFLKOJNIY-UHFFFAOYSA-N Magnesium ion Chemical compound [Mg+2] JLVVSXFLKOJNIY-UHFFFAOYSA-N 0.000 description 1
- CPLXHLVBOLITMK-UHFFFAOYSA-N Magnesium oxide Chemical compound [Mg]=O CPLXHLVBOLITMK-UHFFFAOYSA-N 0.000 description 1
- 229920000881 Modified starch Polymers 0.000 description 1
- 208000028571 Occupational disease Diseases 0.000 description 1
- 239000011398 Portland cement Substances 0.000 description 1
- 229910000831 Steel Inorganic materials 0.000 description 1
- QAOWNCQODCNURD-UHFFFAOYSA-N Sulfuric acid Chemical compound OS(O)(=O)=O QAOWNCQODCNURD-UHFFFAOYSA-N 0.000 description 1
- 238000005299 abrasion Methods 0.000 description 1
- 239000012615 aggregate Substances 0.000 description 1
- 238000004378 air conditioning Methods 0.000 description 1
- 239000004411 aluminium Substances 0.000 description 1
- 229910052782 aluminium Inorganic materials 0.000 description 1
- XAGFODPZIPBFFR-UHFFFAOYSA-N aluminium Chemical compound [Al] XAGFODPZIPBFFR-UHFFFAOYSA-N 0.000 description 1
- 229910052898 antigorite Inorganic materials 0.000 description 1
- 239000008346 aqueous phase Substances 0.000 description 1
- 239000007864 aqueous solution Substances 0.000 description 1
- 239000012298 atmosphere Substances 0.000 description 1
- 230000008901 benefit Effects 0.000 description 1
- 229920002988 biodegradable polymer Polymers 0.000 description 1
- 239000004621 biodegradable polymer Substances 0.000 description 1
- 239000003124 biologic agent Substances 0.000 description 1
- 230000033228 biological regulation Effects 0.000 description 1
- 229920001222 biopolymer Polymers 0.000 description 1
- 229910052599 brucite Inorganic materials 0.000 description 1
- 239000011111 cardboard Substances 0.000 description 1
- 238000004113 cell culture Methods 0.000 description 1
- 229920002678 cellulose Polymers 0.000 description 1
- 239000001913 cellulose Substances 0.000 description 1
- 238000002468 ceramisation Methods 0.000 description 1
- 230000008859 change Effects 0.000 description 1
- 230000009920 chelation Effects 0.000 description 1
- 239000013043 chemical agent Substances 0.000 description 1
- 238000003776 cleavage reaction Methods 0.000 description 1
- 230000015271 coagulation Effects 0.000 description 1
- 238000005345 coagulation Methods 0.000 description 1
- 239000002131 composite material Substances 0.000 description 1
- 230000003750 conditioning effect Effects 0.000 description 1
- 239000004035 construction material Substances 0.000 description 1
- 238000000354 decomposition reaction Methods 0.000 description 1
- 229910003460 diamond Inorganic materials 0.000 description 1
- 239000010432 diamond Substances 0.000 description 1
- 201000010099 disease Diseases 0.000 description 1
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 1
- 238000010616 electrical installation Methods 0.000 description 1
- 238000010292 electrical insulation Methods 0.000 description 1
- 239000012772 electrical insulation material Substances 0.000 description 1
- 235000019197 fats Nutrition 0.000 description 1
- 239000003337 fertilizer Substances 0.000 description 1
- 239000012467 final product Substances 0.000 description 1
- 229910052839 forsterite Inorganic materials 0.000 description 1
- 239000012634 fragment Substances 0.000 description 1
- 239000007792 gaseous phase Substances 0.000 description 1
- KRHYYFGTRYWZRS-UHFFFAOYSA-N hydrofluoric acid Substances F KRHYYFGTRYWZRS-UHFFFAOYSA-N 0.000 description 1
- 125000002887 hydroxy group Chemical group [H]O* 0.000 description 1
- 238000000338 in vitro Methods 0.000 description 1
- 238000001727 in vivo Methods 0.000 description 1
- 239000002440 industrial waste Substances 0.000 description 1
- 150000002484 inorganic compounds Chemical class 0.000 description 1
- 229910010272 inorganic material Inorganic materials 0.000 description 1
- 229910003480 inorganic solid Inorganic materials 0.000 description 1
- 238000009413 insulation Methods 0.000 description 1
- 239000012774 insulation material Substances 0.000 description 1
- 150000002500 ions Chemical class 0.000 description 1
- 150000002505 iron Chemical class 0.000 description 1
- UQSXHKLRYXJYBZ-UHFFFAOYSA-N iron oxide Inorganic materials [Fe]=O UQSXHKLRYXJYBZ-UHFFFAOYSA-N 0.000 description 1
- 235000013980 iron oxide Nutrition 0.000 description 1
- VBMVTYDPPZVILR-UHFFFAOYSA-N iron(2+);oxygen(2-) Chemical class [O-2].[Fe+2] VBMVTYDPPZVILR-UHFFFAOYSA-N 0.000 description 1
- 238000002955 isolation Methods 0.000 description 1
- 229940017800 lactobacillus casei Drugs 0.000 description 1
- 229940072205 lactobacillus plantarum Drugs 0.000 description 1
- 229910052899 lizardite Inorganic materials 0.000 description 1
- HCWCAKKEBCNQJP-UHFFFAOYSA-N magnesium orthosilicate Chemical compound [Mg+2].[Mg+2].[O-][Si]([O-])([O-])[O-] HCWCAKKEBCNQJP-UHFFFAOYSA-N 0.000 description 1
- 230000007246 mechanism Effects 0.000 description 1
- 230000004060 metabolic process Effects 0.000 description 1
- 239000002207 metabolite Substances 0.000 description 1
- 150000002739 metals Chemical class 0.000 description 1
- 230000002906 microbiologic effect Effects 0.000 description 1
- 238000002156 mixing Methods 0.000 description 1
- 235000019426 modified starch Nutrition 0.000 description 1
- QPJSUIGXIBEQAC-UHFFFAOYSA-N n-(2,4-dichloro-5-propan-2-yloxyphenyl)acetamide Chemical compound CC(C)OC1=CC(NC(C)=O)=C(Cl)C=C1Cl QPJSUIGXIBEQAC-UHFFFAOYSA-N 0.000 description 1
- 229910052757 nitrogen Inorganic materials 0.000 description 1
- 231100000252 nontoxic Toxicity 0.000 description 1
- 230000003000 nontoxic effect Effects 0.000 description 1
- 239000010450 olivine Substances 0.000 description 1
- 229910052609 olivine Inorganic materials 0.000 description 1
- 230000020477 pH reduction Effects 0.000 description 1
- 238000012856 packing Methods 0.000 description 1
- 239000011087 paperboard Substances 0.000 description 1
- 238000005192 partition Methods 0.000 description 1
- 230000007170 pathology Effects 0.000 description 1
- 230000000149 penetrating effect Effects 0.000 description 1
- 229920000747 poly(lactic acid) Polymers 0.000 description 1
- 239000004626 polylactic acid Substances 0.000 description 1
- 239000000843 powder Substances 0.000 description 1
- 238000002203 pretreatment Methods 0.000 description 1
- 229930010796 primary metabolite Natural products 0.000 description 1
- 230000002035 prolonged effect Effects 0.000 description 1
- 238000000746 purification Methods 0.000 description 1
- 229910052611 pyroxene Inorganic materials 0.000 description 1
- 239000002994 raw material Substances 0.000 description 1
- 239000012429 reaction media Substances 0.000 description 1
- 238000001953 recrystallisation Methods 0.000 description 1
- 239000011819 refractory material Substances 0.000 description 1
- 210000002345 respiratory system Anatomy 0.000 description 1
- 239000004576 sand Substances 0.000 description 1
- 230000007017 scission Effects 0.000 description 1
- 230000001932 seasonal effect Effects 0.000 description 1
- 230000003248 secreting effect Effects 0.000 description 1
- 238000010583 slow cooling Methods 0.000 description 1
- 239000010802 sludge Substances 0.000 description 1
- 239000000243 solution Substances 0.000 description 1
- 239000007858 starting material Substances 0.000 description 1
- 239000010959 steel Substances 0.000 description 1
- 125000001424 substituent group Chemical group 0.000 description 1
- 238000006467 substitution reaction Methods 0.000 description 1
- 239000000758 substrate Substances 0.000 description 1
- 239000001117 sulphuric acid Substances 0.000 description 1
- 235000011149 sulphuric acid Nutrition 0.000 description 1
- 229920002994 synthetic fiber Polymers 0.000 description 1
- 231100000167 toxic agent Toxicity 0.000 description 1
- 239000003440 toxic substance Substances 0.000 description 1
- 230000007704 transition Effects 0.000 description 1
- IBPRKWGSNXMCOI-UHFFFAOYSA-N trimagnesium;disilicate;hydrate Chemical compound O.[Mg+2].[Mg+2].[Mg+2].[O-][Si]([O-])([O-])[O-].[O-][Si]([O-])([O-])[O-] IBPRKWGSNXMCOI-UHFFFAOYSA-N 0.000 description 1
- ULEFFCDROVNTRO-UHFFFAOYSA-N trimagnesium;disodium;dihydroxy(oxo)silane;iron(3+) Chemical compound [Na+].[Na+].[Mg+2].[Mg+2].[Mg+2].[Fe+3].[Fe+3].O[Si](O)=O.O[Si](O)=O.O[Si](O)=O.O[Si](O)=O.O[Si](O)=O.O[Si](O)=O.O[Si](O)=O.O[Si](O)=O ULEFFCDROVNTRO-UHFFFAOYSA-N 0.000 description 1
- 238000009423 ventilation Methods 0.000 description 1
- 239000010455 vermiculite Substances 0.000 description 1
- 229910052902 vermiculite Inorganic materials 0.000 description 1
- 235000019354 vermiculite Nutrition 0.000 description 1
- 239000011782 vitamin Substances 0.000 description 1
- 229930003231 vitamin Natural products 0.000 description 1
- 229940088594 vitamin Drugs 0.000 description 1
- 235000013343 vitamin Nutrition 0.000 description 1
- 238000004017 vitrification Methods 0.000 description 1
- 238000009941 weaving Methods 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A62—LIFE-SAVING; FIRE-FIGHTING
- A62D—CHEMICAL MEANS FOR EXTINGUISHING FIRES OR FOR COMBATING OR PROTECTING AGAINST HARMFUL CHEMICAL AGENTS; CHEMICAL MATERIALS FOR USE IN BREATHING APPARATUS
- A62D3/00—Processes for making harmful chemical substances harmless or less harmful, by effecting a chemical change in the substances
- A62D3/02—Processes for making harmful chemical substances harmless or less harmful, by effecting a chemical change in the substances by biological methods, i.e. processes using enzymes or microorganisms
-
- A—HUMAN NECESSITIES
- A62—LIFE-SAVING; FIRE-FIGHTING
- A62D—CHEMICAL MEANS FOR EXTINGUISHING FIRES OR FOR COMBATING OR PROTECTING AGAINST HARMFUL CHEMICAL AGENTS; CHEMICAL MATERIALS FOR USE IN BREATHING APPARATUS
- A62D3/00—Processes for making harmful chemical substances harmless or less harmful, by effecting a chemical change in the substances
- A62D3/30—Processes for making harmful chemical substances harmless or less harmful, by effecting a chemical change in the substances by reacting with chemical agents
- A62D3/35—Processes for making harmful chemical substances harmless or less harmful, by effecting a chemical change in the substances by reacting with chemical agents by hydrolysis
-
- A—HUMAN NECESSITIES
- A62—LIFE-SAVING; FIRE-FIGHTING
- A62D—CHEMICAL MEANS FOR EXTINGUISHING FIRES OR FOR COMBATING OR PROTECTING AGAINST HARMFUL CHEMICAL AGENTS; CHEMICAL MATERIALS FOR USE IN BREATHING APPARATUS
- A62D3/00—Processes for making harmful chemical substances harmless or less harmful, by effecting a chemical change in the substances
- A62D3/30—Processes for making harmful chemical substances harmless or less harmful, by effecting a chemical change in the substances by reacting with chemical agents
- A62D3/36—Detoxification by using acid or alkaline reagents
-
- A—HUMAN NECESSITIES
- A62—LIFE-SAVING; FIRE-FIGHTING
- A62D—CHEMICAL MEANS FOR EXTINGUISHING FIRES OR FOR COMBATING OR PROTECTING AGAINST HARMFUL CHEMICAL AGENTS; CHEMICAL MATERIALS FOR USE IN BREATHING APPARATUS
- A62D2101/00—Harmful chemical substances made harmless, or less harmful, by effecting chemical change
- A62D2101/40—Inorganic substances
- A62D2101/41—Inorganic fibres, e.g. asbestos
-
- A—HUMAN NECESSITIES
- A62—LIFE-SAVING; FIRE-FIGHTING
- A62D—CHEMICAL MEANS FOR EXTINGUISHING FIRES OR FOR COMBATING OR PROTECTING AGAINST HARMFUL CHEMICAL AGENTS; CHEMICAL MATERIALS FOR USE IN BREATHING APPARATUS
- A62D2203/00—Aspects of processes for making harmful chemical substances harmless, or less harmful, by effecting chemical change in the substances
- A62D2203/02—Combined processes involving two or more distinct steps covered by groups A62D3/10 - A62D3/40
Definitions
- the present invention relates to a process for treating an asbestos containing material so as to transform the asbestos itself and enable a possible reuse of the products deriving from said treatment.
- Asbestos is the commercial name attributed to several natural minerals having a fibrous structure and belonging to the class of silicates. In modern times some of these minerals were widely used because of their excellent technological properties: they have good resistance to heat and fire, to the action of chemical and biological agents and to abrasion and wear, have high mechanical strength and good flexibility, easily bind with construction materials and have good sound absorbing and heat insulating properties. Because of all these properties and its low cost asbestos was widely used in industrial and building applications and manufactured components, in means of transport and in the domestic sphere. In particular, the raw fibre was processed in order to obtain various products adaptable to multiple uses. In these products, the asbestos fibres may either be free, or strongly or weakly bound.
- brittle materials which can be crumbled by hand pressure alone due to the poor internal cohesion.
- compact materials which can be crumbled into powder only with the aid of mechanical machinery.
- the materials in a brittle matrix are undoubtedly the most dangerous, as the fibres can be dispersed into the air with extreme ease and thus inhaled. Asbestos in a compact matrix, given its nature, does not tend to release fibres and a hazardous situation may arise only if it is abraded, deteriorated or sawed.
- ACM Asbestos Containing Materials
- Asbestos has been undoubtedly most widely used in the building sector, in particular in the form of a composite of asbestos and cement, or so-called asbestos-cement.
- asbestos was largely used as a coating on beams or floors, applied with spraying and spreading techniques.
- the heat-resistant mixture was composed of varying percentages of asbestos and other materials (vermiculite, sand or cellulose fibres) and binding materials (gypsum and/or calcium carbonate): the result was a continuous layer, soft to the touch, of a colour varying from dark grey to white.
- the main ACW transformation processes are based on chemical treatments relying on the action of acids and thermal and mechanochemical treatments, though recently biochemical and microbiological methods have been studied.
- the waste is melted at temperatures of between 1300 and 1400°C together with particular additives, such as blast furnace slag or industrial sludge, forming a mixture with a high metal content.
- the slag thus derived is crystallized at a controlled temperature: in this manner one obtains products with very high mechanical strength, particularly suitable as coating and protective surfaces in the building, mechanical and chemical industries.
- lithification is based on melting ACW derived from the removal of insulation from railway carriages at a temperature of 1300-1400°C. Slow cooling brings about the crystallization of pyroxenes, olivine and iron oxides. The final result of the treatment is the production of inert materials, which can be recovered for a variety of applications.
- Microbiological methods have also been developed for the transformation of asbestos using bacteria, in particular Lactobacillus casei and Lactobacillus plantarum (see for example the article by I.A. Stanik, K. Cedzy ⁇ ska, S. ⁇ kowska; Fresenius Environmental Bulletin, Vol. 15, Issue 7, pp.640-643 (2006 )).
- the method is based on breaking down the crystalline layers of Brucite (magnesium-oxygen) present within the crystalline layers of Chrysotile as a consequence of the indirect metabolism of the bacterial cultures used.
- the decomposition of crystalline layers seems to be due to the acidification of the reaction environment, thanks to the presence of metabolites secreted by the bacteria, which also include lactic acid.
- the hypothesized reaction mechanism is achieved through a substitution of Mg 2+ ions by H + ions, which are present in great excess. The magnesium thus released reacts with the lactic acid present to form soluble salts.
- the Applicant thus addressed the problem of devising and fine-tuning a process for treating asbestos containing materials under relatively mild conditions, which is able to combine efficacy with both ecological and economic sustainability.
- the Applicant therefore judged it expedient to couple a thermal treatment to an acid treatment in which the asbestos containing material in a broken-down form is subjected to the action not of a common acidic chemical reagent, but rather of an acidic industrial waste product, i.e. milk whey, which, besides creating an acidic environment, contributes bacterial components believed to favour an attack on the material itself.
- the asbestos is then inertized by means of a high-temperature, high-pressure hydrothermal process.
- the present invention thus relates to a process for treating an asbestos containing material, comprising:
- the milk whey is preferably exhausted milk whey.
- the hydrothermal process is carried out at a pH value of from 1 to 7, more preferably from 2 to 6.
- the asbestos containing material can be any product which includes asbestos in a fibrillar form, in brittle matrices or a cement matrix, or also compact polymeric matrices (generally synthetic or cellulosic polymers). If asbestos containing materials are used in compact non-cement matrices, a pre-treatment of the material which is capable of freeing the fibres from the matrix itself is preferably carried out, as is better illustrated below.
- the asbestos containing material can be:
- the aforesaid asbestos containing materials are generally delivered as waste to be disposed of, and in order to transport them safely they are preferably wrapped with a protective film, which is preferably made from a biodegradable polymer (e.g. starch derivatives, polylactic acid, polyhydroxyalkanoates).
- a biodegradable polymer e.g. starch derivatives, polylactic acid, polyhydroxyalkanoates
- the material to be treated is preferably kept wrapped in said film also during the grinding process, which is carried out in order to obtain said material in a broken-down form.
- Grinding has the purpose of obtaining fragments of a size which can vary within wide margins, such as to render the material itself compatible with the specific equipment used for the subsequent steps and to increase the exchange surface and thereby reduce treatment times.
- the size can therefore vary from micrometric dimensions to several centimetres, for example between 1 and 5 cm.
- the grinding process can be carried out with various types of machinery, depending on the specific material to be treated.
- the grinding step is carried out on the material immersed in a tank containing the milk whey. This prevents the asbestos fibres from being dispersed in the environment during grinding. Said grinding can preferably be achieved by means of diamond cutters, which are capable of working immersed in the milk whey.
- the material to be treated comprises asbestos in a fibrillar form dispersed in a compact polymeric matrix (generally synthetic or cellulosic polymers, e.g. paper or cardboard), prior to the treatment with milk whey the asbestos containing material is preferably subjected to a thermal pre-treatment in order to cause combustion of the polymeric matrix and to release the asbestos fibrils.
- a compact polymeric matrix generally synthetic or cellulosic polymers, e.g. paper or cardboard
- milk whey As regards milk whey, as is known, the latter consists in the liquid part which separates from the curd as a result of the process of coagulation of the casein present in the milk. It is thus a by-product of the production of cheese or casein from milk. Whey can be considered as the aqueous phase of milk. This phase is formed by the whole of the substances dissolved in the water (including soluble proteins), irrespective of their molecular size, and by substances with low molecular weights.
- the composition of milk whey is highly complex and mainly comprises water, lactose, protein, fats and vitamins. Thanks to the presence of large amounts of protein and other nutritionally valid compounds, milk whey is further used in various ways, in particular for the production of cheese and other milk derivatives.
- the waste liquid phase which derives from this second processing is the so-called "exhausted milk whey", which is considered non-hazardous special waste.
- Exhausted milk whey which is considered non-hazardous special waste.
- Table a typical composition of exhausted milk whey is shown: Substances Present Average Amount (% by weight) Lactose 4.0 ⁇ 4.6 Protein 0.10 ⁇ 0.15 Fats 0.15 ⁇ 0.30 Salts 0.9 ⁇ 1.1 Organic acids 0.20 ⁇ 0.25 pH 3.5 ⁇ 5.2
- exhausted milk whey can have a variable composition depending on the specific manufacturing processes carried out in the dairy, which differ from product a product and also show seasonal variability.
- a particularly innovative and economically relevant aspect of the present invention is precisely that it provides a process which not only allows asbestos containing waste to be treated so as to render it no longer hazardous to health, but also enables the disposal of huge amounts of milk whey, and in particular exhausted milk whey, which represents a serious ecological problem for the dairy industry.
- the cement matrix in which the asbestos may be englobed in the form of fibrils is gradually transformed, with the production of carbon dioxide, so as to release the asbestos fibrils, which remain suspended in the liquid inside the tank where the treatment is carried out.
- At least one organic acid can be added to the milk whey, in particular lactic acid or oxalic acid, so as to bring the pH to a value of between 1 and 3.
- the amount of milk whey used in the process according to the present invention can vary from 2 to 100 times by weight, preferably from 20 to 40, relative to the weight of the total material to be treated.
- the treatment with milk whey is carried out under stirring for a time of from 12 to 120 hours, more preferably from 48 to 72 hours, at a temperature of from 20 to 90°C, more preferably from 30 to 50°C.
- carbon dioxide is formed as a result of the action of the acidic environment on the carbonates present in the cement.
- This step of the process is preferably carried out in a closed tank, so that the carbon dioxide formed can be collected and conveyed into a plant where it is used without being emitted into the atmosphere: for example, a plant for the production of natural gas or biogas or for the production of biopolymers (e.g. polyhydroxyalkanoates) using specific cell cultures.
- the solid phase containing the asbestos is conveyed, for example by suction, into a hydrothermal reactor (preferably made of steel) where the hydrothermal treatment is carried out at a temperature of from 120°C to 250°C, preferably from 160°C to 200°C, and at a pressure of from 5 to 20 bar, preferably from 8 to 15 bar.
- a hydrothermal reactor preferably made of steel
- the hydrothermal process is preferably carried out at a pH value of from 1 to 7, more preferably from 2 to 6. If the pH of the solid phase is not sufficiently acidic for an optimal execution of the process, it is possible to add at least one organic acid, in particular lactic acid or oxalic acid, to the reaction medium so as to bring the pH to the desired value.
- at least one organic acid in particular lactic acid or oxalic acid
- the Applicant has found that excessively prolonging this step may lead to an unexpected increase in the concentration of asbestos fibres. This is attributable to the formation of Chrysotile crystals, mainly during the prolonged stages of the process and this to an insufficient transformation.
- To prevent the crystallization of fibrous Chrysotile during the hydrothermal process it is preferable to add at least one aluminium and/or iron salt to the reaction bath. It is believed that such salts are able to favour, in the event of recrystallization of the asbestos during the treatment, the formation of lizardite and/or antigorite instead of the unwanted Chrysotile phase.
- the hydrothermal treatment is preferably carried out for a time of from 12 to 168 hours, preferably from 72 to 100 hours, and preferably no longer than 120 hours.
- the asbestos containing solid phase deriving from the first step of the process generally has water or, preferably, milk whey added to it, the latter being able to contribute the necessary amount of water.
- At least one chelating agent selected for instance from among: oxalic acid, lactic acid, formic acid, or salts thereof.
- the chelation of magnesium ions is believed to promote cleavage of the Chrysotile crystal planes. Once the structural order characterizing it has be broken down, the asbestos (and in particular Chrysotile) will no longer be capable of packing according to its distinctive basic structural units and undergo a phase change.
- At least one chelating agent in this step could also be useful for extracting some important constituent and substituent elements of asbestos, such as, for example, magnesium, nickel and iron, which can be recovered, for example, by means of electrochemical processes.
- the process according to the present invention leads to the obtainment of different byproducts, which can be individually used for a variety of purposes.
- the following are obtained:
- the mixture was kept under stirring at a temperature of 30°C for an overall time of 80 hours. At the end of this treatment the pH was 5.82.
- the resulting solid phase after undergoing filtration, was placed in a hydrothermal reactor together with 60 mL of exhausted milk whey, at a temperature of 150°C and a pressure of between 7 and 9 bar for 72 hours.
- the resulting sample contained some constituent elements of the cement matrix (calcium carbonate, quartz and anorthite), whereas the percentage by weight of asbestos fibres decreased considerably, from 12% in the untreated sample to 2% in the solid residue at the end of the treatment.
- the resulting solid phase after undergoing filtration, was placed in a hydrothermal reactor together with 50 mL of exhausted milk whey, at a temperature of 190°C and a pressure of between 8 and 12 bar for 60 hours.
- the resulting sample contained some constituent elements of the cement matrix (calcium carbonate, quartz and anorthite), whereas the percentage by weight of asbestos fibres decreased considerably, from 12% in the untreated sample to 5% in the solid residue at the end of the treatment.
- the mixture was kept under stirring at a temperature of 40°C for an overall time of 48 hours. At the end of this treatment the pH was 6.45.
- the resulting solid phase after undergoing filtration, was placed in a hydrothermal reactor together with 70 mL of exhausted milk whey, at a temperature of 200°C and a pressure of between 15 and 20 bar for 72 hours.
Landscapes
- Chemical & Material Sciences (AREA)
- Health & Medical Sciences (AREA)
- Business, Economics & Management (AREA)
- Toxicology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Emergency Management (AREA)
- Life Sciences & Earth Sciences (AREA)
- Engineering & Computer Science (AREA)
- Biochemistry (AREA)
- Biomedical Technology (AREA)
- Microbiology (AREA)
- Molecular Biology (AREA)
- Processing Of Solid Wastes (AREA)
Description
- The present invention relates to a process for treating an asbestos containing material so as to transform the asbestos itself and enable a possible reuse of the products deriving from said treatment.
- Asbestos is the commercial name attributed to several natural minerals having a fibrous structure and belonging to the class of silicates. In modern times some of these minerals were widely used because of their excellent technological properties: they have good resistance to heat and fire, to the action of chemical and biological agents and to abrasion and wear, have high mechanical strength and good flexibility, easily bind with construction materials and have good sound absorbing and heat insulating properties. Because of all these properties and its low cost asbestos was widely used in industrial and building applications and manufactured components, in means of transport and in the domestic sphere. In particular, the raw fibre was processed in order to obtain various products adaptable to multiple uses. In these products, the asbestos fibres may either be free, or strongly or weakly bound. If they are weakly bound, they are referred to as brittle materials, which can be crumbled by hand pressure alone due to the poor internal cohesion. If they are strongly bound, they are referred to as compact materials, which can be crumbled into powder only with the aid of mechanical machinery. The materials in a brittle matrix are undoubtedly the most dangerous, as the fibres can be dispersed into the air with extreme ease and thus inhaled. Asbestos in a compact matrix, given its nature, does not tend to release fibres and a hazardous situation may arise only if it is abraded, deteriorated or sawed.
- There are a vast number of types of Asbestos Containing Materials (ACM) which have extremely varied and differentiated characteristics and uses. The U.S. Federal Register lists over 3000 finished objects which contain asbestos. ACM can be classified into three categories
- (a) Surface Materials: these include ACM sprayed or distributed by spreading over surfaces (weight-bearing elements, walls, ceilings) for soundproofing, heat insulating and decorative purposes;
- (b) Heat Insulation Materials: these include the ACM used to prevent the formation of condensate in pipes, ducts, boilers, tanks and in various components of water cooling systems, as well as in heating, ventilation and air conditioning systems;
- (c) Sundry Materials: this category embraces all of the other ACM, as in false-ceilings, sheathing, fabrics, etc.
- Asbestos has been undoubtedly most widely used in the building sector, in particular in the form of a composite of asbestos and cement, or so-called asbestos-cement. Moreover, in order to avoid or limit damage in the event of a fire, asbestos was largely used as a coating on beams or floors, applied with spraying and spreading techniques. The heat-resistant mixture was composed of varying percentages of asbestos and other materials (vermiculite, sand or cellulose fibres) and binding materials (gypsum and/or calcium carbonate): the result was a continuous layer, soft to the touch, of a colour varying from dark grey to white. Asbestos minerals were used as additives in cement conglomerates to improve their mechanical characteristics: the phases were usually Portland cement, water, aggregates, fibres of Chrysotile, Crocidolite and/or Amosite (more rarely), until eventually only Chrysotile was used. The asbestos content was variable and could reach 50% by weight depending on the type of product to be obtained.
- Today it is a universally recognized fact that asbestos is one of the materials most hazardous to human health among those present in living and work environments; this hazard results in severe pathologies prevalently affecting the respiratory tract. Although an etiological connection between the inhalation of airborne asbestos fibres and the onset of specific diseases was already hypothesized at the start of the last century, it was not until the 1990s that regulations consistent with the hazardousness of the material were introduced in various countries.
- Ascertainment of the harm that this raw material caused to workers obliged the governments of all countries in the world to address the problem, in consideration of the exceedingly high social costs ensuing from occupational diseases developed by operators in the sector over the years.
- It should be noted that the accumulation of Asbestos Containing Waste (ACW) in landfills does not solve the problem, but rather simply passes it on to future generations: it is thus important to devise a strategy that allows ACW to be transformed and subsequently exploited as materials in the production of new products which are totally safe from an environmental viewpoint.
- There are currently in use a number of processes, in addition to ACW "inertization" and "isolation", which are suitable for transforming it and have the aim of completely eliminating the hazardousness thereof. "Inertization" processes comprise procedures for conditioning in matrices of varying nature which prevent the dispersal of asbestos fibres in the environment, whereas "transformation" processes act directly upon the fibrous structure of the mineral itself, transforming it into other phases that are not hazardous to human health.
- The main ACW transformation processes are based on chemical treatments relying on the action of acids and thermal and mechanochemical treatments, though recently biochemical and microbiological methods have been studied.
- Insofar as regards acid treatments, various methods have been developed which envisage the use of both organic and mineral acids to transform ACW so as to obtain secondary materials that are recyclable and often reusable in the ceramics industry. In particular, the effects of mineral acids, such as hydrofluoric, hydrochloric and sulphuric acid, as well as the effects of organic acids such as formic and oxalic acid, have been studied.
- As regards thermal treatments, it is well known that asbestos materials are unstable at high temperatures. Chrysotile, for example, has a tendency to lose the hydroxyl groups at 500-600°C and to be transformed into a different inert mineral phase, Forsterite, which is recrystallized at 820°C. The application of this principle makes it possible to obtain inert materials from ACW, as such or ground, and treated in furnaces at a temperature of 800-950°C. Furthermore, if heating is preceded by compacting of the material, the consequent disorientation of the crystals allows the final product to be used as electrical insulation or refractory material. This process takes the name of ceramization. It is also possible to achieve a vitrification of ACW through a number of processes which are based on melting asbestos containing waste with the addition of different additives within a broad temperature interval (1300-1800°C), followed by rapid cooling with the production of an inert material having an amorphous vitreous structure. However, this solution requires a great deal of energy in order to bring the melting ovens to extremely high, constant temperatures.
- In vitroceramization, on the other hand, the waste is melted at temperatures of between 1300 and 1400°C together with particular additives, such as blast furnace slag or industrial sludge, forming a mixture with a high metal content. The slag thus derived is crystallized at a controlled temperature: in this manner one obtains products with very high mechanical strength, particularly suitable as coating and protective surfaces in the building, mechanical and chemical industries.
- Another technique consists in the so-called lithification, which is based on melting ACW derived from the removal of insulation from railway carriages at a temperature of 1300-1400°C. Slow cooling brings about the crystallization of pyroxenes, olivine and iron oxides. The final result of the treatment is the production of inert materials, which can be recovered for a variety of applications.
- As regards biological treatments, the microbiological action of mosses and lichens on different rocky substrates containing asbestos fibres has been studied both in vivo and in vitro: the hyphae of lichens and fungi are capable of penetrating and secreting chemical compounds (oxalic acid is one of the primary metabolites), some of which can alter the mineralogical structure of asbestos fibres (see for example the article by S.E. Favero-Longo, M. Girlanda, R. Honegger, B. Fubini, R. Piervittori; Mycological Research, Vol. 111, Issue 4, pp. 473-481 (2007)).
- Microbiological methods have also been developed for the transformation of asbestos using bacteria, in particular Lactobacillus casei and Lactobacillus plantarum (see for example the article by I.A. Stanik, K. Cedzyńska, S. Żkowska; Fresenius Environmental Bulletin, Vol. 15, Issue 7, pp.640-643 (2006)). The method is based on breaking down the crystalline layers of Brucite (magnesium-oxygen) present within the crystalline layers of Chrysotile as a consequence of the indirect metabolism of the bacterial cultures used. The decomposition of crystalline layers seems to be due to the acidification of the reaction environment, thanks to the presence of metabolites secreted by the bacteria, which also include lactic acid. The hypothesized reaction mechanism is achieved through a substitution of Mg2+ ions by H+ ions, which are present in great excess. The magnesium thus released reacts with the lactic acid present to form soluble salts.
- However, all the processes that use biochemical and microbiological methods have shown a low degree of asbestos fibre transformation, at times only superficial, without reaching a complete transformation: therefore, up to now such methods have not had applications feasible on an industrial scale.
- Unfortunately, the methods for transforming asbestos containing materials (ACM) known to date have non-negligible disadvantages. In particular, acid treatments lead to the accumulation of a large amount of waste products, which also need to be disposed of. Furthermore, it should be kept in mind that in order to treat millions of tons of ACW (the approximate estimate for Italian territory alone ranges between 20 and 30 million tons) it would be necessary to use enormous amounts of reagents, which would entail non-negligible environmental risks and very high costs. With regard to thermal treatments, the largest disadvantage, besides the enormous amount of energy required to bring the furnaces to very high, constant temperatures, is given by the fact that suitable equipment is highly costly and thus scarcely available across the territory, so that it is necessary to transport the ACW over long distances, with the consequent environmental risks and logistical costs.
- The Applicant thus addressed the problem of devising and fine-tuning a process for treating asbestos containing materials under relatively mild conditions, which is able to combine efficacy with both ecological and economic sustainability.
- The Applicant therefore judged it expedient to couple a thermal treatment to an acid treatment in which the asbestos containing material in a broken-down form is subjected to the action not of a common acidic chemical reagent, but rather of an acidic industrial waste product, i.e. milk whey, which, besides creating an acidic environment, contributes bacterial components believed to favour an attack on the material itself. After said treatment, which frees the asbestos fibrils from the matrix in which they are englobed, the asbestos is then inertized by means of a high-temperature, high-pressure hydrothermal process. At the end of this process one obtains a solid phase consisting essentially of silicates and oxalates together with an organic component resulting from the thermal transformation of the bacterial component, and a liquid phase that is rich in various metal ions (in particular magnesium, nickel, manganese, potassium and calcium), which can be recovered through electrolytic processes.
- The present invention thus relates to a process for treating an asbestos containing material, comprising:
- treating the material with milk whey so as to obtain an acidic liquid phase and a solid phase containing the asbestos;
- subjecting the solid phase containing the asbestos to a hydrothermal process at a temperature of from 120°C to 250°C and at a pressure of from 5 bar to 20 bar.
- In a preferred embodiment, the milk whey is preferably exhausted milk whey.
- In a preferred embodiment, the hydrothermal process is carried out at a pH value of from 1 to 7, more preferably from 2 to 6.
- As regards the asbestos containing material, it can be any product which includes asbestos in a fibrillar form, in brittle matrices or a cement matrix, or also compact polymeric matrices (generally synthetic or cellulosic polymers). If asbestos containing materials are used in compact non-cement matrices, a pre-treatment of the material which is capable of freeing the fibres from the matrix itself is preferably carried out, as is better illustrated below.
- For example, the asbestos containing material can be:
- (a) a material for covering surfaces for the purpose of imparting sound-absorbing, heat-insulating, flameproofing and/or decorative properties, in which the asbestos fibres are mixed with inorganic components (e.g. silicates, gypsum and/or calcium carbonate) and applied by spraying or spreading (for example to obtain flameproof barriers in ducting for electrical installations, or for insulating railway carriages, ships and buses);
- (b) a material in the form of ropes, tapes or sheaths obtained by weaving asbestos fibres, generally in a blend with other natural and synthetic fibres, and usable for wrapping pipes to be heat insulated or electric cables near sources of intense heat, or for producing fireproof fabrics or fabrics with properties of resistance to the corrosive action of acids and bases.
- (c) a material in which the asbestos fibres are contained in a cellulose-based matrix, which can be pressed to obtain sheets to be used, for example, as flameproof barriers or as coverings for bearing surfaces, sleeves or panels of compressed raw fibres, used to insulate pipes for conveying high-temperature steam, or as industrial filters;
- (d) a material obtained by blending asbestos with cement (known as asbestos-cement), in which the asbestos is present in a variable amount of up to 50% by weight, in general between 15 and 20% by weight, relative to the total weight of the material, for the manufacture of building components (e.g. tiles, partitions, pipes, roofing elements, tanks, flat or corrugated sheets, etc.).
- The aforesaid asbestos containing materials are generally delivered as waste to be disposed of, and in order to transport them safely they are preferably wrapped with a protective film, which is preferably made from a biodegradable polymer (e.g. starch derivatives, polylactic acid, polyhydroxyalkanoates).
- To avoid the volatilization of the asbestos fibres, the material to be treated is preferably kept wrapped in said film also during the grinding process, which is carried out in order to obtain said material in a broken-down form. Grinding has the purpose of obtaining fragments of a size which can vary within wide margins, such as to render the material itself compatible with the specific equipment used for the subsequent steps and to increase the exchange surface and thereby reduce treatment times. The size can therefore vary from micrometric dimensions to several centimetres, for example between 1 and 5 cm. The grinding process can be carried out with various types of machinery, depending on the specific material to be treated.
- In a preferred embodiment, the grinding step is carried out on the material immersed in a tank containing the milk whey. This prevents the asbestos fibres from being dispersed in the environment during grinding. Said grinding can preferably be achieved by means of diamond cutters, which are capable of working immersed in the milk whey.
- If the material to be treated comprises asbestos in a fibrillar form dispersed in a compact polymeric matrix (generally synthetic or cellulosic polymers, e.g. paper or cardboard), prior to the treatment with milk whey the asbestos containing material is preferably subjected to a thermal pre-treatment in order to cause combustion of the polymeric matrix and to release the asbestos fibrils.
- As regards milk whey, as is known, the latter consists in the liquid part which separates from the curd as a result of the process of coagulation of the casein present in the milk. It is thus a by-product of the production of cheese or casein from milk. Whey can be considered as the aqueous phase of milk. This phase is formed by the whole of the substances dissolved in the water (including soluble proteins), irrespective of their molecular size, and by substances with low molecular weights. The composition of milk whey is highly complex and mainly comprises water, lactose, protein, fats and vitamins. Thanks to the presence of large amounts of protein and other nutritionally valid compounds, milk whey is further used in various ways, in particular for the production of cheese and other milk derivatives. The waste liquid phase which derives from this second processing is the so-called "exhausted milk whey", which is considered non-hazardous special waste. In the following table a typical composition of exhausted milk whey is shown:
Substances Present Average Amount (% by weight) Lactose 4.0 ÷ 4.6 Protein 0.10 ÷ 0.15 Fats 0.15 ÷ 0.30 Salts 0.9 ÷ 1.1 Organic acids 0.20 ÷ 0.25 pH 3.5 ÷ 5.2 - It should be noted that exhausted milk whey can have a variable composition depending on the specific manufacturing processes carried out in the dairy, which differ from product a product and also show seasonal variability.
- It is worth highlighting that exhausted milk whey, despite being wholly devoid of toxic agents, cannot be disposed of directly in bodies of water due to its high organic content and the presence of complex bacterial flora. For the same reason, treating it by means of classic biological purification systems is exceedingly difficult and costly. A particularly innovative and economically relevant aspect of the present invention is precisely that it provides a process which not only allows asbestos containing waste to be treated so as to render it no longer hazardous to health, but also enables the disposal of huge amounts of milk whey, and in particular exhausted milk whey, which represents a serious ecological problem for the dairy industry.
- Thanks to the acidity of milk whey, and in particular of exhausted milk whey, which generally has pH values from 3.5 to 5.5, and the concomitant presence of bacteria (in particular Lactobacilli), the cement matrix in which the asbestos may be englobed in the form of fibrils is gradually transformed, with the production of carbon dioxide, so as to release the asbestos fibrils, which remain suspended in the liquid inside the tank where the treatment is carried out.
- If the pH of the milk whey is not sufficiently acidic for an optimal execution of the process, at least one organic acid can be added to the milk whey, in particular lactic acid or oxalic acid, so as to bring the pH to a value of between 1 and 3.
- Preferably, the amount of milk whey used in the process according to the present invention can vary from 2 to 100 times by weight, preferably from 20 to 40, relative to the weight of the total material to be treated. The treatment with milk whey is carried out under stirring for a time of from 12 to 120 hours, more preferably from 48 to 72 hours, at a temperature of from 20 to 90°C, more preferably from 30 to 50°C.
- During the treatment of ACM in a brittle or cement matrix with exhausted milk whey, carbon dioxide is formed as a result of the action of the acidic environment on the carbonates present in the cement. This step of the process is preferably carried out in a closed tank, so that the carbon dioxide formed can be collected and conveyed into a plant where it is used without being emitted into the atmosphere: for example, a plant for the production of natural gas or biogas or for the production of biopolymers (e.g. polyhydroxyalkanoates) using specific cell cultures.
- At the end of the treatment with milk whey, the solid phase containing the asbestos is conveyed, for example by suction, into a hydrothermal reactor (preferably made of steel) where the hydrothermal treatment is carried out at a temperature of from 120°C to 250°C, preferably from 160°C to 200°C, and at a pressure of from 5 to 20 bar, preferably from 8 to 15 bar.
- As indicated above, the hydrothermal process is preferably carried out at a pH value of from 1 to 7, more preferably from 2 to 6. If the pH of the solid phase is not sufficiently acidic for an optimal execution of the process, it is possible to add at least one organic acid, in particular lactic acid or oxalic acid, to the reaction medium so as to bring the pH to the desired value.
- As regards the hydrothermal treatment times, the Applicant has found that excessively prolonging this step may lead to an unexpected increase in the concentration of asbestos fibres. This is attributable to the formation of Chrysotile crystals, mainly during the prolonged stages of the process and this to an insufficient transformation. To prevent the crystallization of fibrous Chrysotile during the hydrothermal process it is preferable to add at least one aluminium and/or iron salt to the reaction bath. It is believed that such salts are able to favour, in the event of recrystallization of the asbestos during the treatment, the formation of lizardite and/or antigorite instead of the unwanted Chrysotile phase.
- The hydrothermal treatment is preferably carried out for a time of from 12 to 168 hours, preferably from 72 to 100 hours, and preferably no longer than 120 hours.
- Since the hydrothermal process takes place in the presence of water, the asbestos containing solid phase deriving from the first step of the process generally has water or, preferably, milk whey added to it, the latter being able to contribute the necessary amount of water.
- In order to favour the phase transition from asbestos to nontoxic inorganic compounds, during the hydrothermal treatment it is advisable to add at least one chelating agent, selected for instance from among: oxalic acid, lactic acid, formic acid, or salts thereof.
- The chelation of magnesium ions is believed to promote cleavage of the Chrysotile crystal planes. Once the structural order characterizing it has be broken down, the asbestos (and in particular Chrysotile) will no longer be capable of packing according to its distinctive basic structural units and undergo a phase change.
- Using at least one chelating agent in this step could also be useful for extracting some important constituent and substituent elements of asbestos, such as, for example, magnesium, nickel and iron, which can be recovered, for example, by means of electrochemical processes.
- As illustrated above, the process according to the present invention leads to the obtainment of different byproducts, which can be individually used for a variety of purposes. In particular, the following are obtained:
- 1) an inorganic solid phase deriving from the hydrothermal treatment, which mainly comprises oxalates, carbonates and silicates and is usable as a starting material for the ceramics industry and inorganic inert matrices;
- 2) an organic solid phase deriving from the hydrothermal treatment, consisting mainly of thermally treated bacterial residues and usable as an agricultural fertilizer with a high nitrogen content;
- 3) a liquid phase deriving from the hydrothermal treatment, consisting in an aqueous solution of metal ions, particularly rich in magnesium, nickel, manganese, potassium, iron and calcium, from which the various elemental metals can be electrolytically extracted at a high degree of purity and with substantial financial advantages;
- 4) a gaseous phase deriving from the treatment of the asbestos containing material with the exhausted milk whey, mainly consisting in CO2, which can be used, for example, by employing specific bacterial strains, to generate natural gas or biogas (which can satisfy, at least in part, the energy needs of the asbestos containing material treatment plant) and polymeric material having a high technological value.
- The present invention will now be further illustrated with some examples of embodiments, which are provided for purely illustrative purposes without limiting the scope of the invention itself.
- 4 g of a previously ground asbestos-cement sample was weighed. This was added to 90 mL of exhausted milk whey at pH 4.16.
- The mixture was kept under stirring at a temperature of 30°C for an overall time of 80 hours. At the end of this treatment the pH was 5.82.
- The resulting solid phase, after undergoing filtration, was placed in a hydrothermal reactor together with 60 mL of exhausted milk whey, at a temperature of 150°C and a pressure of between 7 and 9 bar for 72 hours.
- At the end of this second step the resulting sample contained some constituent elements of the cement matrix (calcium carbonate, quartz and anorthite), whereas the percentage by weight of asbestos fibres decreased considerably, from 12% in the untreated sample to 2% in the solid residue at the end of the treatment.
- 3.5 g of a previously ground asbestos-cement sample was weighed. This was added to 80 mL of exhausted milk whey, to which 10 mL of 0.5 M lactic acid was added. The resulting pH was 3.56.
- The mixture was kept under stirring at room temperature for an overall time of 60 hours. At the end of this treatment the pH was 5.12
- The resulting solid phase, after undergoing filtration, was placed in a hydrothermal reactor together with 50 mL of exhausted milk whey, at a temperature of 190°C and a pressure of between 8 and 12 bar for 60 hours.
- At the end of this second step the resulting sample contained some constituent elements of the cement matrix (calcium carbonate, quartz and anorthite), whereas the percentage by weight of asbestos fibres decreased considerably, from 12% in the untreated sample to 5% in the solid residue at the end of the treatment.
- 4 g of a previously ground asbestos-cement sample was weighed. This was added to 70 mL di exhausted milk whey, to which 10 mL of 0.5 M oxalic acid was added. The resulting pH was 2.38.
- The mixture was kept under stirring at a temperature of 40°C for an overall time of 48 hours. At the end of this treatment the pH was 6.45.
- The resulting solid phase, after undergoing filtration, was placed in a hydrothermal reactor together with 70 mL of exhausted milk whey, at a temperature of 200°C and a pressure of between 15 and 20 bar for 72 hours.
- At the end of this second step, a complete transformation of the cement matrix was noted, with the exception of a slight percentage of quartz. The percentage by weight of asbestos fibres decreased considerably, from 12% in the untreated sample to 2.5% at the end of the treatment.
- 3 g of a sample containing free asbestos fibres was weighed; these were quantified in an interval of from 10 to 14% by weight. The sample was added to 50 mL of exhausted milk whey at pH = 3.98 and subjected to a hydrothermal treatment at a temperature of 150°C and a pressure of between 6 and 8 bar for 48 hours.
- At the end of this treatment the percentage by weight of the asbestos fibres had decreased to 2.5%.
- 4 g of a sample containing free asbestos fibres was weighed; these were quantified in an interval of from 10 to 14% by weight. The sample was added to 60 mL of exhausted milk whey and 10 mL of 0.5 M lactic acid for a pH value equal to 3.56. The sample was subsequently subjected to a hydrothermal treatment at a temperature of 180°C and a pressure of between 8 and 12 bar for 60 hours.
- At the end of this treatment the percentage by weight of the asbestos fibres had decreased to 4%.
- 4 g of a sample containing free asbestos fibres was weighed; these were quantified in an interval of from 10 to 14% by weight. The sample was added to 70 mL of exhausted milk whey and 10 mL of 0.5 M oxalic acid for a pH value equal to 2.19. The sample was subsequently subjected to a hydrothermal treatment at a temperature of 150°C and a pressure of between 6 and 8 bar for 72 hours.
- At the end of this treatment the percentage by weight of the asbestos fibres had decreased to 2.5%.
Claims (14)
- Process for treating an asbestos containing material, comprising:treating the material with a milk whey so as to obtain an acidic liquid phase and a solid phase containing the asbestos;subjecting the solid phase containing the asbestos to a hydrothermal process at a temperature of from 120°C to 250°C and at a pressure of from 5 bar to 20 bar.
- Process according to claim 1, wherein the milk whey is exhausted milk whey.
- Process according to any one of the preceding claims, wherein the hydrothermal process is carried out at a pH value of from 1 to 7, preferably from 2 to 6.
- Process according to anyone of the preceding claims, wherein the asbestos containing material includes asbestos in a fibrillar form dispersed into a brittle matrix or a cement matrix, or alternatively in a polymeric compact matrix.
- Process according to anyone of the preceding claims, wherein the asbestos containing material includes asbestos in a fibrillar form dispersed into a polymeric compact matrix, and wherein said material, before the treatment step with the milk whey, is subjected to a thermal pre-treatment to cause combustion of the polymeric matrix and to release the asbestos fibrils.
- Process according to anyone of the preceding claims, wherein the asbestos containing material is previously subjected to a grinding step.
- Process according to claim 6, wherein the grinding step is carried out on the material immersed into a tank containing the milk whey.
- Process according to anyone of the preceding claims, wherein the milk whey is added with at least one organic acid, particularly lactic acid or oxalic acid, so as to obtain a pH value of from 1 to 3.
- Process according to anyone of the preceding claims, wherein the milk whey is employed in an amount of from 2 to 100, preferably from 20 to 40, times by weight relative to the weight of the material to be treated.
- Process according to anyone of the preceding claims, wherein the treatment with the milk whey is carried out under stirring for a time of from 12 to 120 hours, preferably from 48 to 72 hours, at a temperature of from 20 to 90°C, preferably from 30 to 50°C.
- Process according to anyone of the preceding claims, wherein the hydrothermal process is carried out at a temperature of from 160°C to 200°C and at a pressure of from 8 to 15 bar.
- Process according to anyone of the preceding claims, wherein the hydrothermal process is carried out for a time of from 12 to 168 ore, preferably from 72 to 100 hours, and more preferably not longer than 120 hours.
- Process according to anyone of the preceding claims, wherein, before the hydrothermal process, water or, preferably, milk whey is added to the solid phase containing the asbestos.
- Process according to anyone of the preceding claims, wherein, during the hydrothermal process, at least one chelating agent is added, selected for instance from: oxalic acid, lactic acid, formic acid, or salts thereof.
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
ITMI2010A001443A IT1401495B1 (en) | 2010-07-30 | 2010-07-30 | PROCESS FOR THE TREATMENT OF A MATERIAL CONTAINING ASBESTOS |
Publications (2)
Publication Number | Publication Date |
---|---|
EP2428254A1 EP2428254A1 (en) | 2012-03-14 |
EP2428254B1 true EP2428254B1 (en) | 2013-03-27 |
Family
ID=43734300
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
EP11175285A Active EP2428254B1 (en) | 2010-07-30 | 2011-07-26 | Process for treating an asbestos containing material |
Country Status (3)
Country | Link |
---|---|
EP (1) | EP2428254B1 (en) |
ES (1) | ES2419405T3 (en) |
IT (1) | IT1401495B1 (en) |
Cited By (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
FR3126624A1 (en) | 2021-09-09 | 2023-03-10 | Centre National De La Recherche Scientifique (Cnrs) | METHOD FOR TREATMENT OF A PRODUCT CONTAINING ASBESTOS |
Families Citing this family (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN106661596B (en) * | 2014-04-29 | 2021-06-29 | Lebsc公司 | Biochemical modification method for asbestos-containing material |
FR3040317A1 (en) * | 2015-08-31 | 2017-03-03 | Sadoun Alain Agissant Pour Le Compte De La Soc Valmater Sas En Cours De Creation | METHOD OF BIOLOGICALLY REDUCING MAGNESIUM AND / OR IRON QUANTITY OF ASBESTOS WASTE |
WO2019064069A2 (en) * | 2017-09-29 | 2019-04-04 | Tullia Zucca | Process for the destruction of cement, asbestos-containing material and/or other matrix material by simultanfeously subjecting the material to cavitation and acid-based chemical reaction |
EP3731978B1 (en) * | 2017-12-27 | 2023-06-07 | IGL Innovation Foundry S.r.l. | A method and plant for the destruction of the crystalline structure of mineral and manmade fibers |
Family Cites Families (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2007032412A1 (en) * | 2005-09-13 | 2007-03-22 | The Institute For Eco & Economy System Corporation | Hydrothermally solidified material by zero emission-type thermal power system, and process for producing the same |
-
2010
- 2010-07-30 IT ITMI2010A001443A patent/IT1401495B1/en active
-
2011
- 2011-07-26 ES ES11175285T patent/ES2419405T3/en active Active
- 2011-07-26 EP EP11175285A patent/EP2428254B1/en active Active
Cited By (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
FR3126624A1 (en) | 2021-09-09 | 2023-03-10 | Centre National De La Recherche Scientifique (Cnrs) | METHOD FOR TREATMENT OF A PRODUCT CONTAINING ASBESTOS |
WO2023037081A1 (en) | 2021-09-09 | 2023-03-16 | Centre National De La Recherche Scientifique (Cnrs) | Method for treating a product containing asbestos |
Also Published As
Publication number | Publication date |
---|---|
ES2419405T3 (en) | 2013-08-20 |
EP2428254A1 (en) | 2012-03-14 |
IT1401495B1 (en) | 2013-07-26 |
ITMI20101443A1 (en) | 2012-01-31 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
EP2428254B1 (en) | Process for treating an asbestos containing material | |
JP5490104B2 (en) | Durable magnesium oxychloride cement and method therefor | |
US8815758B2 (en) | Silica-based nonflammable material for replacing asbestos and method for preparing same | |
US20100180797A1 (en) | Ceramic Fire Protection Panel and Method for Producing the Same | |
CN111533527A (en) | Environment-friendly high-strength straw cement brick and preparation method thereof | |
KR20130113190A (en) | Ecofriendly cement binder composite | |
He et al. | Effect of pressing pressure on the mechanical properties and water resistance of straw/sawdust-magnesium oxychloride cement composite | |
CN108164138B (en) | Harmless treatment method of medical waste salt | |
JPH10296224A (en) | Method for utilizing waste gypsum board material | |
US10391347B2 (en) | Process for biochemical denaturation of an asbestos-containing material | |
BG65746B1 (en) | Method for producing masonry and facing blocks | |
KR101755124B1 (en) | Method of detoxification for material containing asbestos | |
KR101918998B1 (en) | Plaster blocks recycled with waste perlite and method for manufacturing the same | |
US20180085613A1 (en) | Process for the disposal of acid wastes combining them with asbestos containing materials and/or concrete using synergistic physical, biological and chemical treatments | |
CN1101635A (en) | Carbonized fly ash building block and manufacturing method thereof | |
Chaabane et al. | Efficiency of stabilization/solidification of heavy metals contained in hydroxide sludge waste into metakaolin based geopolymers | |
WO2019064069A2 (en) | Process for the destruction of cement, asbestos-containing material and/or other matrix material by simultanfeously subjecting the material to cavitation and acid-based chemical reaction | |
JPH06321599A (en) | Refractory coating material | |
US10780306B2 (en) | Process for the destruction of matrix material by cavitation and acid-based chemical reaction | |
RU2777311C1 (en) | Fire-resistant heat insulation composition | |
JP2002338327A (en) | Method for producing moisture control building material | |
Chatterjee et al. | Modified Bacteria Incorporated Geopolymer-A Qualitative Approach for an Eco-friendly, Energy-efficient and Self-healing Construction Material | |
CN108751783A (en) | A kind of preparation method of concrete water-proof additive | |
PL217354B1 (en) | Mass for the production of silicate products with higher compressive strength | |
PL120509B1 (en) | Method of manufacture of building products from wet asbestos-cement wastessbesto-cementnykh otkhodov |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
17P | Request for examination filed |
Effective date: 20111103 |
|
AK | Designated contracting states |
Kind code of ref document: A1 Designated state(s): AL AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HR HU IE IS IT LI LT LU LV MC MK MT NL NO PL PT RO RS SE SI SK SM TR |
|
AX | Request for extension of the european patent |
Extension state: BA ME |
|
PUAI | Public reference made under article 153(3) epc to a published international application that has entered the european phase |
Free format text: ORIGINAL CODE: 0009012 |
|
GRAP | Despatch of communication of intention to grant a patent |
Free format text: ORIGINAL CODE: EPIDOSNIGR1 |
|
GRAS | Grant fee paid |
Free format text: ORIGINAL CODE: EPIDOSNIGR3 |
|
GRAA | (expected) grant |
Free format text: ORIGINAL CODE: 0009210 |
|
AK | Designated contracting states |
Kind code of ref document: B1 Designated state(s): AL AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HR HU IE IS IT LI LT LU LV MC MK MT NL NO PL PT RO RS SE SI SK SM TR |
|
AX | Request for extension of the european patent |
Extension state: BA ME |
|
REG | Reference to a national code |
Ref country code: GB Ref legal event code: FG4D |
|
REG | Reference to a national code |
Ref country code: CH Ref legal event code: EP |
|
REG | Reference to a national code |
Ref country code: AT Ref legal event code: REF Ref document number: 602989 Country of ref document: AT Kind code of ref document: T Effective date: 20130415 |
|
REG | Reference to a national code |
Ref country code: IE Ref legal event code: FG4D |
|
REG | Reference to a national code |
Ref country code: DE Ref legal event code: R096 Ref document number: 602011001158 Country of ref document: DE Effective date: 20130523 |
|
PG25 | Lapsed in a contracting state [announced via postgrant information from national office to epo] |
Ref country code: LT Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20130327 Ref country code: BG Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20130627 Ref country code: NO Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20130627 Ref country code: SE Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20130327 |
|
REG | Reference to a national code |
Ref country code: ES Ref legal event code: FG2A Ref document number: 2419405 Country of ref document: ES Kind code of ref document: T3 Effective date: 20130820 |
|
REG | Reference to a national code |
Ref country code: LT Ref legal event code: MG4D |
|
PG25 | Lapsed in a contracting state [announced via postgrant information from national office to epo] |
Ref country code: GR Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20130628 Ref country code: LV Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20130327 Ref country code: SI Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20130327 Ref country code: FI Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20130327 |
|
REG | Reference to a national code |
Ref country code: NL Ref legal event code: VDEP Effective date: 20130327 |
|
PG25 | Lapsed in a contracting state [announced via postgrant information from national office to epo] |
Ref country code: BE Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20130327 Ref country code: HR Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20130327 |
|
PG25 | Lapsed in a contracting state [announced via postgrant information from national office to epo] |
Ref country code: NL Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20130327 Ref country code: RO Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20130327 Ref country code: PT Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20130729 Ref country code: SK Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20130327 Ref country code: CZ Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20130327 Ref country code: IS Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20130727 Ref country code: EE Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20130327 |
|
PG25 | Lapsed in a contracting state [announced via postgrant information from national office to epo] |
Ref country code: PL Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20130327 Ref country code: CY Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20130327 |
|
PG25 | Lapsed in a contracting state [announced via postgrant information from national office to epo] |
Ref country code: DK Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20130327 |
|
PLBE | No opposition filed within time limit |
Free format text: ORIGINAL CODE: 0009261 |
|
STAA | Information on the status of an ep patent application or granted ep patent |
Free format text: STATUS: NO OPPOSITION FILED WITHIN TIME LIMIT |
|
PG25 | Lapsed in a contracting state [announced via postgrant information from national office to epo] |
Ref country code: MC Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20130327 |
|
26N | No opposition filed |
Effective date: 20140103 |
|
REG | Reference to a national code |
Ref country code: DE Ref legal event code: R097 Ref document number: 602011001158 Country of ref document: DE Effective date: 20140103 |
|
REG | Reference to a national code |
Ref country code: IE Ref legal event code: MM4A |
|
PG25 | Lapsed in a contracting state [announced via postgrant information from national office to epo] |
Ref country code: IE Free format text: LAPSE BECAUSE OF NON-PAYMENT OF DUE FEES Effective date: 20130726 |
|
REG | Reference to a national code |
Ref country code: CH Ref legal event code: PL |
|
PG25 | Lapsed in a contracting state [announced via postgrant information from national office to epo] |
Ref country code: LI Free format text: LAPSE BECAUSE OF NON-PAYMENT OF DUE FEES Effective date: 20140731 Ref country code: CH Free format text: LAPSE BECAUSE OF NON-PAYMENT OF DUE FEES Effective date: 20140731 |
|
PG25 | Lapsed in a contracting state [announced via postgrant information from national office to epo] |
Ref country code: SM Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20130327 |
|
PG25 | Lapsed in a contracting state [announced via postgrant information from national office to epo] |
Ref country code: MT Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20130327 |
|
PG25 | Lapsed in a contracting state [announced via postgrant information from national office to epo] |
Ref country code: HU Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT; INVALID AB INITIO Effective date: 20110726 Ref country code: MK Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20130327 Ref country code: RS Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20130627 Ref country code: LU Free format text: LAPSE BECAUSE OF NON-PAYMENT OF DUE FEES Effective date: 20130726 |
|
REG | Reference to a national code |
Ref country code: FR Ref legal event code: PLFP Year of fee payment: 6 |
|
REG | Reference to a national code |
Ref country code: FR Ref legal event code: PLFP Year of fee payment: 7 |
|
REG | Reference to a national code |
Ref country code: FR Ref legal event code: PLFP Year of fee payment: 8 |
|
PGFP | Annual fee paid to national office [announced via postgrant information from national office to epo] |
Ref country code: TR Payment date: 20190725 Year of fee payment: 9 |
|
PGFP | Annual fee paid to national office [announced via postgrant information from national office to epo] |
Ref country code: GB Payment date: 20200123 Year of fee payment: 9 |
|
GBPC | Gb: european patent ceased through non-payment of renewal fee |
Effective date: 20200726 |
|
PG25 | Lapsed in a contracting state [announced via postgrant information from national office to epo] |
Ref country code: GB Free format text: LAPSE BECAUSE OF NON-PAYMENT OF DUE FEES Effective date: 20200726 |
|
PG25 | Lapsed in a contracting state [announced via postgrant information from national office to epo] |
Ref country code: TR Free format text: LAPSE BECAUSE OF NON-PAYMENT OF DUE FEES Effective date: 20200726 |
|
PGFP | Annual fee paid to national office [announced via postgrant information from national office to epo] |
Ref country code: ES Payment date: 20220815 Year of fee payment: 12 Ref country code: DE Payment date: 20220727 Year of fee payment: 12 Ref country code: AT Payment date: 20220719 Year of fee payment: 12 |
|
PGFP | Annual fee paid to national office [announced via postgrant information from national office to epo] |
Ref country code: FR Payment date: 20220725 Year of fee payment: 12 |
|
REG | Reference to a national code |
Ref country code: DE Ref legal event code: R119 Ref document number: 602011001158 Country of ref document: DE |
|
REG | Reference to a national code |
Ref country code: AT Ref legal event code: MM01 Ref document number: 602989 Country of ref document: AT Kind code of ref document: T Effective date: 20230726 |
|
PG25 | Lapsed in a contracting state [announced via postgrant information from national office to epo] |
Ref country code: AT Free format text: LAPSE BECAUSE OF NON-PAYMENT OF DUE FEES Effective date: 20230726 |
|
PG25 | Lapsed in a contracting state [announced via postgrant information from national office to epo] |
Ref country code: DE Free format text: LAPSE BECAUSE OF NON-PAYMENT OF DUE FEES Effective date: 20240201 Ref country code: AT Free format text: LAPSE BECAUSE OF NON-PAYMENT OF DUE FEES Effective date: 20230726 |
|
PG25 | Lapsed in a contracting state [announced via postgrant information from national office to epo] |
Ref country code: FR Free format text: LAPSE BECAUSE OF NON-PAYMENT OF DUE FEES Effective date: 20230731 |
|
PGFP | Annual fee paid to national office [announced via postgrant information from national office to epo] |
Ref country code: IT Payment date: 20240126 Year of fee payment: 13 |
|
REG | Reference to a national code |
Ref country code: ES Ref legal event code: FD2A Effective date: 20240902 |
|
PGFP | Annual fee paid to national office [announced via postgrant information from national office to epo] |
Ref country code: AL Payment date: 20240115 Year of fee payment: 13 |